We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Coronary CTA a Cost-Effective, Noninvasive Alternative to Cardiac Catheterization

By HospiMedica International staff writers
Posted on 25 May 2010
According to new research, noninvasive coronary computed tomography angiography (CTA) is a cost-effective alternative to invasive cardiac catheterization in the care of patients who have positive stress test results but a less than 50% chance of actually having significant coronary artery disease (CAD). More...


The study was published in the May 2010 issue of the American Journal of Roentgenology (AJR). CAD is a narrowing of the blood vessels that supply blood and oxygen to the heart. If left untreated, it can lead to a heart attack. "Patients with positive stress test results but no heart-related symptoms, as well as patients with a positive stress test with atypical chest pain often receive referrals for cardiac catheterization for the evaluation of CAD,” said the study's lead author, Ethan J. Halpern, M.D., professor, department of radiology at Jefferson Medical College (Philadelphia, PA, USA), and director, cardiac CT at Thomas Jefferson University Hospital. "Coronary CTA is an alternative, noninvasive diagnostic imaging test that can be used to effectively triage these patients.”

The study compared the false-negative rates, false-positive rates, costs, and radiation exposure of direct referral of patients for cardiac catheterization with the values associated with performing coronary CTA before catheterization. "At a 50% prevalence of CAD, we found that performing coronary CTA before cardiac catheterization results in an average cost saving of US$789 per patient with a false-negative rate of 2.5% and average additional radiation exposure of 1 mSv - 2 mSv, which is minimal,” said Dr. Halpern.

According to the study results, when a patient with an expected CAD prevalence less than 85% is found to have a positive stress test result, coronary CTA is a less expensive alternative to direct performance of cardiac catheterization. Recent studies have demonstrated that diagnostic cardiac catheterization of patients with atypical symptoms will demonstrate significant CAD less than half of the time. If the pretest probability of CAD is low, the coronary CTA findings are more likely to obviate cardiac catheterization and thereby reduce both the cost and effective radiation dose of the workup.

Related Links:
Jefferson Medical College



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.